Search
Close this search box.

October 23, 2026

TGC 2026: Tec-Do Launches Navos Pro for Results-Driven AI for Work

Guangzhou, China, Oct. 24, 2026 (GLOBE NEWSWIRE) — Tec-Do today hosted Technology Growth Conference 2026 (TGC 2026) in Guangzhou under the theme “AI is Profitable.” Featuring AI pioneer Dr. Kevin Knight and speakers from OpenAI, Google, Alibaba, ByteDance and Tencent, the conference explored how AI can deliver measurable business value. At the event, Tec-Do launched […]

Read More

Live Trading Now Runs in the Same App Clients Use to Open and Fund Accounts

Clients of EBC Financial Group can now trade from the same app they use to open, fund, and manage their accounts LONDON, Oct. 23, 2026 (GLOBE NEWSWIRE) — EBC Financial Group (EBC) has expanded live trading in the EBC App, bringing account management, funding tools, and trade execution together on one mobile platform. First introduced […]

Read More

Zana Möhlmann from Singapore crowned Global Bartender of the Year 2026 at the prestigious Diageo World Class Global Finals event in Edinburgh

Top bartenders from 49 countries competed in Scotland for the coveted title World Class Global Bartender of the Year EDINBURGH, United Kingdom, Oct. 22, 2026 (GLOBE NEWSWIRE) — Zana Möhlmann from Singapore has been crowned Diageo World Class Global Bartender of the Year 2026 at the world’s biggest cocktail competition, taking top place among finalists […]

Read More

Antalpha Increases Investment in Aurelion with US$2 Million Share Subscription

SINGAPORE, Oct. 22, 2026 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (NASDAQ: ANTA) (“Antalpha”), a leading institutional digital asset financing platform, today announced that its wholly owned subsidiary, Antalpha Capital (HK) Limited, has entered into a share subscription agreement with Aurelion Inc. (NASDAQ: AURE) (“Aurelion” or the “Company”). Under the agreement, Antalpha, through Antalpha Capital […]

Read More

Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development

Collaboration aims to improve trial planning and expand patient access to biomarker-matched studies in Australia Highlights Collaboration aims to accelerate precision oncology research in Australia Combines Fortrea’s experience in oncology clinical trials with Omico’s Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) program Together, Fortrea and Omico offer more efficient investigator site selection and faster […]

Read More

Recent Posts

Recent Posts